Correction: Mol Cancer 22, 145 (2023)
Following the publication of the original article [1], the authors Yang Liu, Yueting Hu and Jinqi Xue are all the first author who contributed equally to the manuscript, however, the sentence ”Yang Liu, Yueting Hu and Jinqi Xue contributed equally to this work” is missing in the published version. The missing sentence has been added in this correction note article.
References
Liu Y, Hu Y, Xue J, et al. Advances in immunotherapy for triple-negative breast cancer. Mol Cancer. 2023;22:145. https://doi.org/10.1186/s12943-023-01850-7.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1186/s12943-023-01850-7.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Liu, Y., Hu, Y., Xue, J. et al. Correction: Advances in immunotherapy for triple-negative breast cancer. Mol Cancer 22, 154 (2023). https://doi.org/10.1186/s12943-023-01858-z
Published:
DOI: https://doi.org/10.1186/s12943-023-01858-z